Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 1

Epidemiology of Shiga toxin-producing other than serotype O157:H7 in England, 2016–2023 Open Access

Abstract

Shiga toxin-producing (STEC) infections are of public health concern as STEC can cause large national foodborne outbreaks of severe gastrointestinal disease, particularly in the young and elderly. In recent years, the implementation of PCR by diagnostic microbiology laboratories has improved the detection of STEC, and there has been an increase in notifications of cases of non-O157 STEC. However, the extent this increase in caseload can be attributed to the improved detection by PCR, or a true increase in non-O157 STEC infections, is unknown.

Epidemiological and microbiological data and analyses describing the trends in non-O157 STEC in England since the implementation of PCR are limited.

Demographic, microbiological and clinical characteristics of non-O157 STEC from 8 years (2016–2023) of laboratory surveillance data were analysed to understand the recent trends in non-O157 serotypes and the incidence of disease in England.

All human isolates of STEC non-O157 detected between 2016 and 2023 were extracted from the laboratory surveillance system. Microbiological data were analysed and linked to clinical outcomes.

There was an almost 10-fold increase in diagnoses of non-O157 STEC from 2016 (=297) to 2023 (=2341). A total of 9378 isolates of non-O157 STEC were detected, comprising 338 different serotypes, and were linked to 9311 individuals. A higher proportion of non-O157 STEC cases were female (56%) and aged between 20 and 39 years (27%). The most common non-O157 serotypes were O26:H11 (16%), O146:H21 (12%), O91:H14 (11%), O128:H2 (6%), O145:H28 (5%) and O103:H2 (4%). STEC O26:H11 was more frequently reported in under 5s than any other age group (38%), whereas the other common serotypes were more frequently isolated from adults. , which has been associated with greater disease severity, was detected in 18% of cases. Where clinical details were available, 27% of non-O157 cases were admitted to the hospital and 6% developed HUS. Cases of STEC O145:H28 reported a higher rate of hospitalisation than other non-O157 STEC cases. The serotypes most likely to be associated with progression to HUS were O26:H11 (9%) and O145:H28 (7%). STEC harbouring (19%), (11%) and (11%) were most frequently isolated from cases with HUS.

The implementation of widespread PCR testing in England has facilitated better surveillance of STEC non-O157, with respect to establishing the true incidence and burden of disease of non-O157 STEC and monitoring the emergence of highly virulent strains.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): clinical symptoms , Shiga toxin-producing Escherichia coli , surveillance and virulence profile
Funding
This study was supported by the:
  • National Institute for Health Research Health Protection Research Unit (Award 111815)
    • Principle Award Recipient: ClaireJenkins
© 2025 Crown Copyright
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001947
2025-01-10
2025-01-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/1/jmm001947.html?itemId=/content/journal/jmm/10.1099/jmm.0.001947&mimeType=html&fmt=ahah

References

  1. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26:822–880 [View Article] [PubMed]
     [Google Scholar]
  2. Koutsoumanis K, Allende A, Alvarez‐Ordóñez A, Bover‐Cid S, Chemaly M et al. Pathogenicity assessment of Shiga toxin‐producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC. EFSA Journal 2020; 18:e05967 [View Article]
     [Google Scholar]
  3. Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect 2015; 143:3475–3487 [View Article] [PubMed]
     [Google Scholar]
  4. Lindsey RL, Prasad A, Feldgarden M, Gonzalez-Escalona N, Kapsak C et al. Identification and characterization of ten Escherichia coli strains encoding novel Shiga Toxin 2 subtypes, Stx2n as well as Stx2j, Stx2m, and Stx2o, in the United States. Microorganisms 2023; 11:2561 [View Article] [PubMed]
     [Google Scholar]
  5. Byrne L, Adams N, Jenkins C. Association between Shiga Toxin-producing Escherichia coli O157:H7 stx gene subtype and disease severity, England, 2009-2019. Emerg Infect Dis 2020; 26:2394–2400 [View Article] [PubMed]
     [Google Scholar]
  6. Heredia N, García S. Animals as sources of food-borne pathogens: a review. Anim Nutr 2018; 4:250–255 [View Article] [PubMed]
     [Google Scholar]
  7. Butt S, Allison L, Vishram B, Greig DR, Aird H et al. Epidemiological investigations identified an outbreak of Shiga toxin-producing Escherichia coli serotype O26:H11 associated with pre-packed sandwiches. Epidemiol Infect 2021; 149:e178 [View Article] [PubMed]
     [Google Scholar]
  8. Jones G, Lefèvre S, Donguy M-P, Nisavanh A, Terpant G et al. Outbreak of Shiga toxin-producing Escherichia coli (STEC) O26 paediatric haemolytic uraemic syndrome (HUS) cases associated with the consumption of soft raw cow’s milk cheeses, France, March to May 2019. Eurosurveillance 2019; 24:22 [View Article]
     [Google Scholar]
  9. Mulchandani R, Brehmer C, Butt S, Vishram B, Harrison M et al. Outbreak of Shiga toxin-producing Escherichia coli O157 linked with consumption of a fast-food product containing imported cucumbers, United Kingdom, August 2020. Int J Infect Dis 2021; 110 Suppl 1:S62–S68 [View Article] [PubMed]
     [Google Scholar]
  10. Vishram B, Jenkins C, Greig DR, Godbole G, Carroll K et al. The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England. J Med Microbiol 2021; 70:001375 [View Article] [PubMed]
     [Google Scholar]
  11. UKHSA Shiga Toxin-Producing Escherichia Coli (STEC) Data: 2021 2024
     [Google Scholar]
  12. Chattaway MA, Dallman TJ, Gentle A, Wright MJ, Long SE et al. Whole genome sequencing for Public Health Surveillance of Shiga Toxin-producing Escherichia coli other than serogroup O157. Front Microbiol 2016; 7:258 [View Article] [PubMed]
     [Google Scholar]
  13. UKHSA Public Health Operational Guidance for Shiga Toxin-Producing Escherichia Coli (STEC). Including STEC O157 and Non-O157 Infections 2023
     [Google Scholar]
  14. Hoyle DV, Keith M, Williamson H, Macleod K, Mathie H et al. Prevalence and epidemiology of non-O157 Escherichia coli serogroups O26, O103, O111, and O145 and Shiga Toxin gene carriage in Scottish Cattle, 2014-2015. Appl Environ Microbiol 2021; 87:10 [View Article] [PubMed]
     [Google Scholar]
  15. Pearce MC, Jenkins C, Vali L, Smith AW, Knight HI et al. Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams. Appl Environ Microbiol 2004; 70:1708–1716 [View Article] [PubMed]
     [Google Scholar]
  16. Hoyle DV, Wee BA, Macleod K, Chase-Topping ME, Bease AG et al. Phylogenetic relationship and virulence composition of Escherichia coli O26:H11 cattle and human strain collections in Scotland; 2002-2020. Front Microbiol 2023; 14:1260422 [View Article] [PubMed]
     [Google Scholar]
  17. Love NK, Elliot AJ, Chalmers RM, Douglas A, Gharbia S et al. Impact of the COVID-19 pandemic on gastrointestinal infection trends in England, February-July 2020. BMJ Open 2022; 12:e050469 [View Article] [PubMed]
     [Google Scholar]
  18. UKHSA Outbreak of Shiga Toxin-Producing E. Coli (STEC) O145 and Unseasonably High Reporting of Non-O157 STEC Infections in the UK, December 2023 2023
     [Google Scholar]
  19. Vusirikala A, Rowell S, Dabke G, Fox G, Bell J et al. Shedding and exclusion from childcare in children with Shiga toxin-producing Escherichia coli, 2018-2022. Epidemiol Infect 2024; 152:e42 [View Article] [PubMed]
     [Google Scholar]
  20. FSA Greencore Group recalls sandwiches, wraps and salads because of possible contamination with E. coli; 2024 https://www.food.gov.uk/news-alerts/alert/fsa-prin-30-2024
  21. FSA Mrs Kirkham’s Lancashire Cheese Ltd recalls Lancashire Cheese because of possible contamination with E. Coli; 2023 https://www.food.gov.uk/newsalerts/alert/fsa-prin-50-2023
  22. Carbonari CC, Miliwebsky ES, Zolezzi G, Deza NL, Fittipaldi N et al. The importance of Shiga Toxin-producing Escherichia coli O145:NM[H28]/H28 infections in Argentina, 1998-2020. Microorganisms 2022; 10:582 [View Article] [PubMed]
     [Google Scholar]
  23. Den Ouden A, Greig DR, Rodwell EV, Tripodo F, Olonade I et al. Escherichia coli encoding Shiga toxin subtype Stx2f causing human infections in England, 2015-2022. J Med Microbiol 2023; 72: [View Article] [PubMed]
     [Google Scholar]
  24. Byrne L, Douglas A, Launders N, Godbole G, Lynn R et al. Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: a prospective cohort study. Epidemiol Infect 2023; 151:e160 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001947
Loading
Epidemiology of Shiga toxin-producing Escherichia coli other than serotype O157:H7 in England, 2016–2023
J. Med. Microbiol. 74, 001947 (2025); https://doi.org/10.1099/jmm.0.001947
/content/journal/jmm/10.1099/jmm.0.001947
/content/journal/jmm/10.1099/jmm.0.001947
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error